Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015;6(4):453-68.
doi: 10.4155/tde.14.123.

Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacy

Affiliations
Review

Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacy

Drew A Spencer et al. Ther Deliv. 2015.

Abstract

Malignant glioma is a relentless burden to both patients and clinicians, and calls for innovation to overcome the limitations in current management. Glioma therapy using viruses has been investigated to accentuate the nature of a virus, killing a host tumor cell during its replication. As virus mediated approaches progress with promising therapeutic advantages, combination therapy with chemotherapy and oncolytic viruses has emerged as a more synergistic and possibly efficacious therapy. Here, we will review malignant glioma as well as prior experience with oncolytic viruses, chemotherapy and combination of the two, examining how the combination can be optimized in the future.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Immunological and genetic effects of chemotherapy
(A) Effects of the chemotherapeutic agents temozolomide, cyclophosphamide, cisplatin and 5-FU on the local tumor environment. Depletion of Tregs and MDSCs allows infiltration of CD4+ and CD8+ effector T cells. (B) Cytotoxic effects of chemotherapeutic agents. TMZ and CPA induce intra- and interstrand DNA cross-links. Etoposide allows for accumulation of double stranded DNA breaks. Rapamycin and other inhibitors of the PI3K/Akt/mTOR pathway decrease DNA replication and cell proliferation. 5-FU inhibits thymidylate synthase and uracil is incorporated into DNA instead of thymidine, inhibiting DNA synthesis. 5-FU: 5-Fluorouracil; CPA: Cyclophosphamide; MDSC: Myeloid derived suppressor cells; mTOR: Mammalian target of rapamycin; PI3K: Phosphatidylinositol 3-kinase; TMZ: Temozolomide.

Similar articles

Cited by

References

    1. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359(5):492–507. - PubMed
    1. Mcgirt MJ, Chaichana KL, Gathinji M, et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg. 2009;110(1):156–162. - PubMed
    1. Stupp R, Mason WP, Van Den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–996. - PubMed
    1. Ramirez YP, Weatherbee JL, Wheelhouse RT, Ross AH. Glioblastoma multiforme therapy and mechanisms of resistance. Pharmaceuticals. 2013;6(12):1475–1506. - PMC - PubMed
    1. Kelly E, Russell SJ. History of oncolytic viruses: genesis to genetic engineering. Mol Ther. 2007;15(4):651–659. - PubMed

Publication types

Substances

LinkOut - more resources